Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-05

FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Gattex (teduglutide) submitted by Takeda Pharmaceuticals America.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GATTEX (teduglutide)

Snippet

SUPPL AP for GATTEX (TEDUGLUTIDE)